Pharmaceutical composition for use as a contraceptive

CAFC
  • US 6,787,531 B1
  • Filed: 08/31/2000
  • Issued: 09/07/2004
  • Est. Priority Date: 08/31/1999
  • Status: Expired due to Fees
First Claim
Patent Images

1. A pharmaceutical composition comprising from about 2 mg to about 4 mg of micronized drospirenone particles, about 0.01 mg to about 0.05 mg of 17α

  • -ethinylestradiol, and one or more pharmaceutically acceptable carriers, the composition being in an oral dose form exposed to the gastric environment upon dissolution, and the composition being effective for oral contraception in a human female.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×